Analysis of clinical effects of neoadjuvant chemotherapy in advanced epithelial ovarian cancer.

CONCLUSIONS: In comparison to PCS, NACT-ICS can improve the intraoperative conditions, increase the cytoreductive rate, reduce the bleeding of operation, reduce the operation time and increase the clinical remission rate, but it has no impact on PFS and OS. PMID: 30003748 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research